Recall Record

Santa Clara, CA, United States

Agilent Technologies, Inc. recalls

4 recalls recorded since 2018, most recently on 20 March 2025. 3 are listed as ongoing. Status and classification are as published by the FDA.

Recalls4
Ongoing (FDA)3
Terminated or completed1
Class I (FDA)0

Ongoing Class II Medical devices

Recall started
20 March 2025
Reason
DNA Labeling Kit for use in sample labeling to be hybridized to oligonucleotide microarrays has a component, Human Reference DNA Female aliquot, affected by a mosaic aberration that may result in Chromosome 12 baseline shift, which may lead to false positive/negative results, resulting in diagnosis delay, and may lead to delayed treatment of a treatable genetic disorder.
Distribution
US distribution to the state of: MA and OUS (International) distribution to countries of: Spain, Italy, Japan, Colombia, Poland
Initiated
Voluntary: Firm initiated
Recall number
Z-1544-2025

Ongoing Class II Medical devices

Recall started
2 April 2024
Reason
There is the potential for the front plexiglass door of the automated slide processing system to break causing potential injury.
Distribution
Worldwide - US Nationwide distribution in the states of CA, TN, MI, MD, MA, OR, AK, MO, NC, NH, GA, RI and the countries of Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Denmark, Finland, France, Germany, Hong Kong, Spain, Italy, Japan, Malaysia, Netherland, New Zealand, Nor
Initiated
Voluntary: Firm initiated
Recall number
Z-1919-2024

Ongoing Class III Medical devices

Recall started
20 May 2022
Reason
Label provided for substrate vail contained incorrect expiration date.
Distribution
U.S. Nationwide distribution in the states of NY and VA.
Initiated
Voluntary: Firm initiated
Recall number
Z-1384-2022

Terminated Class II Medical devices

Recall started
15 August 2018
Terminated
28 September 2021
Reason
When utilizing specific software versions of an LC/MS device, and Batch at a Glance in Compound Table view, a defect occurs when a new sample(s) is inserted. This defect creates a mismatch between the sample name and the column header whereby the sample header will be offset by one sample. The recalling firm requests that you discontinue using this workflow to generate reports because the Quant batch table will not display fully analyzed results or save any changes made.
Distribution
US Nationwide. distribution.
Initiated
Voluntary: Firm initiated
Recall number
Z-2359-2019

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.